ArticleViruses2023

Efficacy and Safety of Sofosbuvir/Velpatasvir Plus Ribavirin in Patients with Hepatitis C Virus-Related Decompensated Cirrhosis.

Steven Flamm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.